Masimo said Rad-57 pulse co-oximeter will be available to all designated medical treatment facilities and operational field units across the Department of Defense’s global healthcare system from first responders to definitive care.

The department will initially use the Rad-57 to measure oxygen saturation (SpO2), using Masimo’s SET Measure-through Motion and Low Perfusion pulse oximetry, and provide accurate measurements, even under the most challenging conditions.

The Rad-57 also features Masimo rainbow pulse co-oximetry and allows clinicians to noninvasively monitor multiple blood constituents including total hemoglobin, oxygen content, carboxyhemoglobin , methemoglobin, Pleth Variability Index and perfusion index.

Masimo CEO and board chairman Joe Kiani said, "We are honored our life-saving technology will be with soldiers to help them come home."